Opendata, web and dolomites
H2020 projects about "placebo"
The page lists 25 projects related to the topic "placebo".
| # | |||
|---|---|---|---|
| 1 | FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone | 2015 |
| 2 | NEPHSTROM | Novel Stromal Cell Therapy for Diabetic Kidney Disease | 2015 |
| 3 | BETA3_LVH | A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease | 2015 |
| 4 | GLORIA | Comparing the effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rheumatoid arthritis | 2015 |
| 5 | RETHRIM | Restoring tissue regeneration in patients with visceral Graft versus Host Disease. | 2015 |
| 6 | FATHER TRIALS | Father Trials: Hormonal and Behavioral Experiments on Prenatal and Postnatal Parenting | 2016 |
| 7 | NISCI | Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European clinical proof of concept trial | 2016 |
| 8 | MemoMCI | Targeting reconsolidation to strengthen memories in individuals with Mild Cognitive Impairment | 2016 |
| 9 | IEDAT | Intra Erythrocyte Dexamethasone in the treatment of Ataxia Telangiectasia | 2016 |
| 10 | MAST4HEALTH | Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH). | 2016 |
| 11 | ReGenHeart | Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory anginaA phase II randomized, double-blinded, placebo-controlled study | 2017 |
| 12 | TreatER | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery | 2017 |
| 13 | PACE | A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies | 2017 |
| 14 | PIMS | Mechanistic studies of long chain omega-3 fatty acid supplementation and inflammation in metabolic syndrome. | 2017 |
| 15 | GAIT | From symptom relief to disease modifying allergy treatment with Glycan-Allergen Immunotherapy | 2017 |
| 16 | EBOVAC2 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861 | 2014 |
| 17 | NEIMO | Neuronal regulation of immunity | 2017 |
| 18 | HIT-CF | Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond) | 2018 |
| 19 | HIPGEN | Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial | 2018 |
| 20 | Soraprazan | Soraprazan - a new regenerative therapy for Stargardt's disease | 2017 |
| 21 | AIMS-2-TRIALS | Autism Innovative Medicine Studies – 2 – Trials | 2018 |
| 22 | BETTER-B | BETTER TREATMENTS FOR BREATHLESSNESS IN PALLIATIVE AND END OF LIFE CARE | 2019 |
| 23 | NECESSITY | NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients | 2019 |
| 24 | PD-MIND | Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug | 2019 |
| 25 | STOPFOP | Saracatinib Trial tO Prevent FOP | 2019 |